Clinical Trials · NCT06222437
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
- Phase
- Phase 1
- Recruitment status
- Withdrawn
- Sponsor
- Methodist Health System
- Enrollment
- 0
- Start date
- Feb 2026
- Locations
- See registry
- Primary endpoint
- Number of appropriate weekly dose